IPP Placement & Intracavernosal Block

Starting soon · Phase 4

Conditions studied: Erectile Dysfunction (ED)

In brief

The inflatable penile prosthesis (IPP) is the gold standard for surgical management of erectile dysfunction (ED) and there is no consensus on the best postoperative pain management regimen. In the wake of the opioid epidemic, postoperative pain management is heavily scrutinized. The National Institute of Health estimated over 81,000 individuals died following overdose of any opioids in 2022 alone; of these, over 14,000 deaths were linked to prescription opioids. Thus, strategies to minimize postoperative pain should not only improve patient experience but also lessen the need to escalate to opioid usage.

Key facts

Study ID

NCT07246642

Run by

Wake Forest University Health Sciences

People needed

100

Starts

2026-09-01

Expected to finish

2027-10-01

Last updated by the study team

2026-05-26

Who can join

Age: 21 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Any patient undergoing primary three-piece inflatable penile prosthesis (IPP) placement at Lexington Medical Center

You may not qualify if…

• Patients undergoing revision and/or secondary IPP placement
• Patients taking prescribed narcotic medications at the time of IPP surgery
• Patients undergoing concomitant Peyronie's Disease surgery (modeling, plication, grafting) at the time of IPP surgery
• Patients with liver and/or renal disease

Where it is running

• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.